Robert B. Jones - Nov 20, 2023 Form 4 Insider Report for ACURA PHARMACEUTICALS, INC (ACUR)

Role
President & CEO
Signature
/s/ Robert B. Jones
Stock symbol
ACUR
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4
Date filed
11/20/2023, 12:08 PM
Previous filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACUR Common Stock Options Exercise +40K +6.63% 644K Nov 20, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACUR Restricted Stock Unit (2021 Plan) Options Exercise -40K -100% 0 Nov 20, 2023 Common Stock 40K $0.01 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents exchange of restricted stock units.
F2 Par value of $.01 was paid by Reporting Person upon exchange of Restricted Stock Units for stock.
F3 Not Applicable.
F4 40,000 Restricted Stock Units were granted on March 16, 2022 and were 100% vested on December 31, 2022